| Literature DB >> 26962456 |
Arebu Issa Bilal1, Zelalem Tilahun1, Gebremedhin Beedemariam1, Belete Ayalneh2, Bisrat Hailemeskel3, Ephrem Engidawork2.
Abstract
BACKGROUND: Clinical pharmacy service has evolved steadily over the past few decades and is contributing to the 'patient care journey' at all stages. The service improves safety and effectiveness of medicines, thereby avoiding medication errors. As part of this global shift in pharmacy education and practice, Ethiopian Universities revamped the undergraduate pharmacy curriculum and the first graduates came out in July 2013. These graduates were immediately deployed in public hospital settings, with the ultimate aim of providing clinical pharmacy services. As such an initiative is new to the Ethiopian pharmacy sector, there is a need to do assessment of the health care providers' perception and satisfaction towards the service.Entities:
Keywords: Attitude; Clinical pharmacy services; Ethiopia; Health care providers; Perception; Post deployment survey; Satisfaction
Year: 2016 PMID: 26962456 PMCID: PMC4784336 DOI: 10.1186/s40545-016-0058-6
Source DB: PubMed Journal: J Pharm Policy Pract ISSN: 2052-3211
Demographic characteristics of the respondents (N = 594), September, 2014
| Characteristics | Category |
|
|---|---|---|
| Gender | Male | 328 (55.0) |
| Female | 264 (45.0) | |
| Age (in years) | <35 | 507 (90.0) |
| ≥35 | 55 (10.0) | |
| Marital status | Married | 230 (39.0) |
| Single | 353 (59.0) | |
| Divorced | 5 (1.0) | |
| Widowed | 5 (1.0) | |
| Profession | Physicians | 244 (41.0) |
| BSc Nurses | 275 (46.0) | |
| Health Officers | 75 (13.0) | |
| Current area of practice | Internal medicine | 245 (41.0) |
| Pediatrics | 113 (19.0) | |
| Outpatient Department | 76 (13.0) | |
| Surgery | 40 (7.0) | |
| Gynecology/Obstetrics | 36 (6.0) | |
| Emergency Medicine | 31 (5.0) | |
| Psychiatry | 17 (3.0) | |
| Othersa | 35 (6.0) | |
| Total years of work experience in the healthcare system | <2 years | 250 (43.0) |
| 2- 5 years | 158 (27.0) | |
| >5 years | 171 (29.0) | |
| Total years of experience in setting where there is provision of clinical pharmacy service | <1 year | 282 (82.0) |
| ≥1 year | 62 (18.0) |
aIncludes: Oncology, Hematology, TB clinic
Attitude of health care providers towards clinical pharmacy services (N =594), September 2014
| Attitude items | Respondents | Agree | Neutral | Disagree | AOR (95 % CI) |
|---|---|---|---|---|---|
|
|
|
| |||
| Clinical pharmacist participation in medical ward round is desirable | Physicians | 228 (43.02) | 12 (41.38) | 4 (11.43) | 1.90 [0.17–20.39] |
| Nurses | 232 (43.78) | 13 (44.83) | 30 (85.71) | 0.10 [0.01–0.88]* | |
| HO | 70 (13.21) | 4 (13.79) | 1 (2.86) | 1.00 [references] | |
| Total | 530 (89.23) | 29 (4.89) | 35 (5.89) | ||
| Clinical pharmacist can play important role in patient education and counseling | Physicians | 230 (43.73) | 10 (27.03) | 4 (12.90) | 0.92 [0.09–9.22] |
| Nurses | 224 (42.59) | 25 (67.57) | 26 (83.87) | 0.15 [0.02–1.22] | |
| HO | 72 (13.69) | 2 (5.41) | 1 (3.23) | 1.00 | |
| Total | 526 (88.56) | 37 (6.23) | 31 (5.22) | ||
| Clinical pharmacist can monitor patient response to drug therapy from toxicity/side effects perspective | Physicians | 223 (42.97) | 17 (37.78) | 4 (13.34) | 0.92 [0.09–9.22] |
| Nurses | 227 (43.74) | 23 (51.11) | 25 (83.33) | 0.15 [0.02–1.22] | |
| HO | 69 (13.29) | 5 (11.11) | 1 (3.33) | 1.00 | |
| Total | 519 (87.37) | 45 (7.58) | 30 (5.05) | ||
| Clinical pharmacist can monitor patient response to drug therapy from effectiveness perspective | Physicians | 209 (41.97) | 26 (43.33) | 9 (25) | 0.92 [0.09–9.22] |
| Nurses | 221 (44.38) | 29 (48.34) | 25 (69.44) | 0.15 [0.02–1.22] | |
| HO | 68 (13.65) | 5 (8.33) | 2 (5.56) | 1.00 | |
| Total | 498 (87.88) | 60 (6.92) | 36 (5.06) | ||
| Clinical pharmacist can provide drug information to health care professionals such as compatibility, stability, storage, availability | Physicians | 231 (44.25) | 10 (24.39) | 3 (10.00) | 1.82 [0.17–19.55] |
| Nurses | 222 (42.53) | 27 (65.85) | 26 (86.67) | 0.17 [0.02–1.42] | |
| HO | 70 (13.41) | 4 (9.76) | 1 (3.33) | 1.00 | |
| Total | 522 (77.27) | 41 (15.49) | 30 (7.24) | ||
| Clinical pharmacy service enhance patients appreciation and satisfaction | Physicians | 209 (45.53) | 30 (32.61) | 5 (11.63) | 0.41 [0.09–1.90] |
| Nurses | 184 (40.09) | 56 (60.87) | 35 (81.40) | 2.89 [0.82–10.10] | |
| HO | 66 (14.38) | 6 (6.52) | 3 (6.97) | 1.00 | |
| Total | 459 (69.02) | 92 (16.50) | 43 (14.48) | ||
| Clinical pharmacist should take patients medication history at admission | Physicians | 186 (45.37) | 38 (38.78) | 20 (23.26) | 1.33 [0.49–3.61] |
| Nurses | 159 (38.78) | 57 (58.16) | 59 (68.60) | 0.29 [0.12–0.72]* | |
| HO | 65 (15.85) | 3 (3.06) | 7 (8.14) | 1.00 | |
| Total | 410 (74.20) | 98 (15.68 | 86 (10.12) | ||
| Clinical pharmacist should have access to patients chart and have a place to document their service | Physicians | 194 (44.09) | 37 (39.78) | 13 (21.67) | 0.61 [0.12–3.00] |
| Nurses | 185 (42.05) | 45 (48.39) | 45 (75.0) | 0.14 [0.03–0.65]* | |
| HO | 61 (13.86) | 11 (11.83) | 2 (3.33) | 1.00 | |
| Total | 440 (74.20) | 94 (15.68) | 60 (10.12) | ||
| Clinical pharmacist should analyses patient treatment and suggest changes of therapy when necessary | Physicians | 193 (42.05) | 32 (42.31) | 18 (32.14) | 0.38 [0.08–1.82]* |
| Nurses | 203 (44.23) | 36 (46.15) | 36 (64.29) | 0.209 [0.04–0.93]* | |
| HO | 63 (13.73) | 9 (11.54) | 2 (3.57) | 1.00 | |
| Total | 459 (77.14) | 77 (13.11) | 58 (9.75) | ||
| Clinical pharmacist should care about drug products and leave patient care to Doctors, Health Officers and nurses | Physicians | 90 (30.51) | 47 (45.19) | 107 (55.16) | 0.33 [0.16–0.68]* |
| Nurses | 160 (54.24) | 45 (43.27) | 70 (36.08) | 0.77 [0.38–1.57] | |
| HO | 45 (15.25) | 12 (11.54) | 17 (8.76) | 1.00 | |
| Total | 295 (49.75) | 104 (17.53) | 195 (32.72) | ||
| The current setup (infrastructure and environments of your hospital is appropriate for the provisions of clinical pharmacy service) | Physicians | 107 (36.03) | 64 (50.39) | 73 (43.46) | 0.60[0.29–1.23] |
| Nurses | 148 (49.83) | 51 (40.16) | 75 (44.64) | 0.90 [0.45–1.80] | |
| HO | 42 (14.14) | 12 (9.45) | 20 (11.99) | 1.00 | |
| Total | 297 (50.17) | 127 (21.45) | 168 (28.38) | ||
| Clinical pharmacy service initiation is desirable in Ethiopian health care system | Physicians | 210 (44.03) | 27 (35.06) | 7 (17.95) | 1.78 [0.40–7.85] |
| Nurses | 202 (42.35) | 44 (57.14) | 29 (74.36) | 0.34 [0.09–1.30] | |
| HO | 65 (13.63) | 6 (7.80) | 3 (7.69) | 1.00 | |
| Total | 477 (80.44) | 77 (12.98) | 39 (6.58) | ||
| Clinical pharmacist can improve over all patient outcome/quality of patient care | Physicians | 215 (43.79) | 28 (43.75) | 1 (2.63) | 17.80 [1.93–164.86]* |
| Nurses | 208 (42.36) | 35 (54.69) | 32 (84.21) | 0.58 [0.19–1.70] | |
| HO | 68 (13.85) | 1 (1.56) | 6 (13.18) | 1.00 | |
| Total | 491 (82.79) | 64 (10.79) | 39 (6.41) |
Data was analyzed using multivariable regression; *p < 0.05
Association of year of experience with attitude of health care providers on the roles of clinical pharmacists, September 2014
| Attitude items | Years of work Experience | Agree; | Disagree; | AOR (95 % CI) |
|---|---|---|---|---|
| Clinical pharmacist participation in medical ward round is desirable*** | <2 years | 214 (41.3) | 22 (64.6) | 1.00 |
| 2–5 years | 147 (28.4) | 3 (9.0) | 6.70 [1.88–23.91]* | |
| >5 years | 157 (30.3) | 9 (26.4) | 2.76 [1.15–6.61]* | |
| Clinical pharmacist can provide drug information to health care professionals such as compatibility, stability, storage, availability*** | <2 years | 214 (42.0) | 17 (56.7) | 1.00 |
| 2–5 years | 138 (27.0) | 6 (20.0) | 2.84 [1.02–7.94]* | |
| >5 years | 156 (31.0) | 7 (23.3) | 3.41 [1.28–9.11]* | |
| Clinical pharmacist services enhances patients appreciation and satisfaction*** | <2 years | 194 (43.4) | 22 (53.6) | 1.00 |
| 2–5 years | 120 (27.0) | 9 (22.0) | 2.067 [0.86–4.97] | |
| >5 years | 133 (30.0) | 10 (24.3) | 2.399 [1.02–5.64]* |
*Data was analyzed by multivariable logistic regression; * p < 0.05; *** Indicates the presence of non–response by respondents; The following 6 items were found to be non–significant; Clinical pharmacist can provide dose recommendations based on patient and drug factors; Clinical pharmacist should take patients medication history at admissions; Clinical pharmacist should have access to patients chart and have a place to document their services; Clinical pharmacist analyses patient treatment and suggest changes of therapy when necessary; Clinical pharmacist should care about drug products and leave patient care to doctors, HOs and nurses; Clinical pharmacy services initiation is desirable in Ethiopian health care system
Level of satisfaction of the health care providers on the roles of clinical pharmacists by work experience, September 2014
| Current Clinical Pharmacists’ Activities in their setting | Years of work experience | Satisfied; | Not satisfied; | AOR (95 % CI) |
|---|---|---|---|---|
| Clinical pharmacists provide timely information on drug availability*** | <2 years | 171 (44.0) | 63 (43.4) | 1.00 |
| 2–5 years | 103 (26.5) | 45 (31.0) | 0.72 [0.42–1.25] | |
| >5 years | 115 (29.5) | 37 (25.5) | 0.50 [0.26–0.98]* | |
| Total | 389 (73.0) | 145 (27.0) | ||
| Clinical pharmacists provide information on appropriate route of administration | <2 years | 166 (43.0) | 68 (47.5) | 1.00 |
| 2–5 years | 111 (28.0) | 37 (26.0) | 1.11 [0.63–1.94] | |
| >5 years | 114 (29.0) | 38 (26.5) | 0.64 [0.33–1.24] | |
| Total | 391 (73.0) | 143 (27.0) | ||
| Clinical pharmacists participate in preventing, detecting and resolving any drug interaction | <2 years | 164 (43.0) | 70 (46.6) | 1.00 |
| 2–5 years | 106 (27.0) | 42 (28.0) | 0.83 [0.48–1.43] | |
| >5 years | 114 (30.0) | 38 (25.3) | 0.57 [0.29–1.11] | |
| Total | 384 (72.0) | 150 (28.0) | ||
| Clinical pharmacist involve in side effect prevention and management | <2 years | 167 (42.0) | 67 (48.5) | 1.00 |
| 2–5 years | 109 (27.5) | 39 (28.2) | 0.92 [0.53–1.58] | |
| >5 years | 120 (30.3) | 32 (23.2) | 0.86 [0.43–1.70] | |
| Total | 396 (74.0) | 138 (26.0) | ||
| Clinical pharmacists counsel patients regarding the safe & appropriate use of medications | <2 years | 172 (43.0) | 62 (46.3) | 1.00 |
| 2–5 years | 111 (28.0) | 37 (27.6) | 0.89 [0.51–1.55] | |
| >5 years | 116 (29.0) | 35 (26.1) | 0.61 [0.31–1.20] | |
| Total | 399 (75.0) | 134 (25.0) | ||
| Clinical pharmacists participate in dose calculation for patients | <2 years | 155 (42.0) | 79 (50.0) | 1.00 |
| 2–5 years | 108 (29.0) | 40 (25.3) | 1.01 [0.59–1.73] | |
| >5 years | 113 (30.5) | 39 (24.6) | 0.68 [0.35–1.31] | |
| Total | 370 (70.0) | 158 (30.0) | ||
| Overall satisfaction towards Clinical pharmacy services in your setting | <2 years | 164 (44.0) | 68 (44.4) | 1.00 |
| 2–5 years | 108 (29.0) | 38 (24.8) | 0.99 [0.58–1.72] | |
| >5 years | 103 (27.5) | 47 (30.7) | 0.57 [0.30–1.10] | |
| Total | 375 (71.0) | 153 (29.0) | ||
| Clinical pharmacists advise about cost effective medication alternatives*** | <2 years | 111 (52.0) | 40 (54.7) | 1.00 |
| 2–5 years | 55 (26.0) | 17 (23.3) | 0.73 [0.33–1.58] | |
| >5 years | 48 (22.4) | 16 (22.0) | 0.24 [0.08–0.68]* | |
| Total | 214 (74.6) | 73 (25.4) | ||
| Clinical pharmacists provide information on alternative drug regimen | <2 years | 118 (52.5) | 33 (52.4) | 1.00 |
| 2–5 years | 57 (25.3) | 16 (25.4) | 0.631 [0.284–1.402] | |
| >5 years | 50 (22.2) | 14 (22.2) | 0.268 [0.094–0.762]* | |
| Total | 225 (58) | 63 (42) | ||
| Clinical pharmacists actively participate in bed side discussions to assist clinicians on therapeutic care plan and drug selection | <2 years | 90 (50.0) | 60 (57.0) | 1.00 |
| 2–5 years | 52 (29.0) | 20 (19.0) | 1.115 [0.550–2.259] | |
| >5 years | 39 (21.5) | 25 (24.0) | 0.359 [0.144–0.890]* | |
| Total | 181 (63.3) | 105 (46.7) |
Data was analyzed by multivariable logistic regression; * p < 0.05; *** Indicates the presence of non–response by respondents; The following other 10 items were found to be not only non–significant but also the satisfaction score was less than 70 %; Clinical pharmacists regularly present in the ward; Clinical pharmacists involve in drug preparation (reconstitution, reformulation, dilution); Clinical pharmacist counsel patients during discharge, Clinical pharmacists document their services in patient care; Clinical pharmacist identify and report adverse drug reaction; Clinical pharmacists participate in dose adjustment for pediatrics and patients with impaired renal and or liver function; Clinical pharmacists advice nurses on compatibility of IV drug administration/admixture; Clinical pharmacists advice nurses on storage/handling of drugs; Clinical pharmacists assist nurses in managing drug infusion rates; Clinical pharmacists actively participate in ward rounds with the health care team
Association of satisfaction score of the health care providers to the area of practice
| Ward | Satisfied ( | Dissatisfied ( | AOR (95 % CI) | |
|---|---|---|---|---|
| Current Clinical Pharmacists Activities in your setting | Internal medicine | 160 (70.0) | 70 (30.0) | 1.00 |
| Pediatrics | 67 (61.0) | 43 (39.0) | 0.70 [0.43–1.14] | |
| Surgery | 20 (53.0) | 18 (47.0) | 0.45 [0.22–0.93]* | |
| Emergency | 16 (61.5) | 10 (38.5) | 0.67 [0.28–1.57] | |
| Outpatient department | 35 (55.5) | 28 (44.5) | 0.55 [0.30–1.00] | |
| Gynecology/Obstetrics | 15 (42.0) | 21 (58.0) | 0.30 [0.14–0.64]* | |
| Psychiatry | 10 (59.0) | 7 (42.0) | 0.57 [0.20–1.60] | |
| Others | 16 (55.0) | 13 (45.0) | 0.51 [0.22–1.17] | |
| Total | 339 (62.0) | 210 (38.0) | ||
| Clinical pharmacists actively participate in ward rounds with the health care team | Internal medicine | 170 (74.0) | 60 (26.0) | 1.00 |
| Pediatrics | 66 (60.0) | 44 (40.0) | 0.551 [0.33–0.90]* | |
| Surgery | 21(55.0) | 17 (45.0) | 0.39 [0.18–0.80]* | |
| Emergency | 14 (54.0) | 12 (46.0) | 0.38 [0.16–0.89]* | |
| Outpatient department | 34 (54.0) | 29 (46.0) | 0.37 [0.20–0.67]* | |
| Gynecology/Obstetrics | 19 (53.0) | 17 (47.0) | 0.37 [0.18–0.79]* | |
| Psychiatry | 14 (82.0) | 3 (18.0) | 1.51 [0.41–5.51] | |
| Others | 15 (52.0) | 14 (48.0) | 0.36 [0.15–0.88]* | |
| Total | 353 (64.0) | 196 (36.0) | ||
| Clinical pharmacists provide timely information on drug availability | Internal medicine | 171 (74.0) | 59 (26.0) | 1.00 |
| Pediatrics | 81 (74.0) | 29 (26.0) | 0.931 [0.55–1.57] | |
| Surgery | 28 (74.0) | 10 (26.0) | 0.84 [0.38–1.88] | |
| Emergency | 21 (80.8) | 5 (19.0) | 1.38 [0.49–3.87] | |
| Outpatient department | 50 (79.0) | 13 (21.0) | 1.12 [0.56–2.25] | |
| Gynecology/Obstetrics | 22 (61.0) | 14 (39.0) | 0.50 [0.23–1.05] | |
| Psychiatry | 13 (76.5) | 4 (23.5) | 1.04 [0.32–3.37] | |
| Others | 16 (55.0) | 13 (45.0) | 0.36 [0.15–0.82]* | |
| Total | 402 (73.0) | 147 (27.0) | ||
| Clinical pharmacists provide information on the appropriate route of administration | Internal medicine | 176 (76.5) | 54 (23.5) | 1.00 |
| Pediatrics | 78 (71.0) | 32 (30.0) | 0.70 [0.41–1.18] | |
| Surgery | 26 (68.0) | 12 (22.0) | 0.53 [0.24–1.16] | |
| Emergency | 24 (92.0) | 2 (8.0) | 3.52 [0.80–15.49] | |
| Outpatient department | 50 (80.0) | 13 (21.0) | 1.10 [0.53–2.25] | |
| Gynecology/Obstetrics | 18 (50.0) | 18 (50) | 0.26 [0.12–0.56]* | |
| Psychiatry | 10 (59.0) | 7 (41.0) | 0.38 [0.137–1.09] | |
| Others | 22 (76.0) | 7 (24.0) | 0.74 [0.29–1.89] | |
| Total | 404 (73.5) | 145 (26.0) | ||
| Clinical pharmacists counsel patients during discharge*** | Internal medicine | 135 (59.0) | 95 (41.0) | 1.00 |
| Pediatrics | 54 (49.0) | 56 (51.0) | 0.66 [0.41–1.06] | |
| Surgery | 22 (58.0) | 16 (42.0) | 0.733 [0.35–1.52] | |
| Emergency | 15 (58.0) | 11 (42.0) | 0.901 [0.39–2.08] | |
| Outpatient department | 29 (46.0) | 34 (54.0) | 0.500 [0.27–0.91]* | |
| Gynecology/Obstetrics | 16 (44.0) | 20 (56.0) | 0.463 [0.22–0.97]* | |
| Psychiatry | 13 (76.5) | 4 (23.5) | 2.094 [0.65–6.72] | |
| Others | 16 (55.0) | 13 (45.0) | 0.746 [0.32–1.70] | |
| Total | 300 (55.0) | 249 (45.0) | ||
| Clinical pharmacists participate in dose calculation for patients | Internal medicine | 161 (70.0) | 69 (30.0) | 1.00 |
| Pediatrics | 77 (70.0) | 33 (30.0) | 1.01 [0.60–1.69] | |
| Surgery | 30 (79.0) | 8 (21.0) | 1.28 [0.54–3.04] | |
| Emergency | 16 (61.5) | 10 (38.5) | 0.59 [0.25–1.41] | |
| Outpatient department | 48 (76.0) | 15 (24.0) | 1.22 [0.62–2.43] | |
| Gynecology/Obstetrics | 17 (47.0) | 19 (53.0) | 0.32 [0.15–0.68]* | |
| Psychiatry | 13 (76.5) | 4 (23.5) | 1.16 [0.35–3.79] | |
| Others | 24 (83.0) | 5 (18.0) | 1.48 [0.52–4.16] | |
| Total | 386 (70.0) | 163 (30.0) | ||
| Clinical pharmacist identify and report adverse drug reactions | Internal medicine | 159 (69.0) | 71 (31.0) | 1.00 |
| Pediatrics | 71 (64.5) | 39 (35.5) | 0.80 [0.48–1.32] | |
| Surgery | 22 (58.0) | 16 (42.0) | 0.44 [0.20–0.94]* | |
| Emergency | 19 (73.0) | 7 (27.0) | 1.09 [0.43–2.76] | |
| Outpatient department | 43 (68.0) | 20 (32.0) | 0.87 [0.45–1.66] | |
| Gynecology/Obstetrics | 21 (58.0) | 15 (42.0) | 0.53 [0.24–1.14] | |
| Psychiatry | 12 (71.0) | 5 (29.0) | 0.89 [0.29–2.78] | |
| Others | 21 (72.0) | 8 (28.0) | 0.83 [0.33–2.04] | |
| Total | 368 (67.0) | 181(33.0) | ||
| Overall satisfaction towards Clinical pharmacy services in your setting*** | Internal medicine | 171 (75.0) | 57 (25.0) | 1.00 |
| Pediatrics | 74 (68.0) | 35 (32.0) | 0.66 [0.39–1.11] | |
| Surgery | 25 (68.0) | 12 (32.0) | 0.56 [0.25–1.24] | |
| Emergency | 21 (81.0) | 5 (19.0) | 1.26 [0.44–3.57] | |
| Outpatient department | 44 (70.0) | 19 (30.0) | 0.72 [0.37–1.40] | |
| Gynecology/Obstetrics | 16 (47.0) | 18 (53.0) | 0.24 [0.11–0.54]* | |
| Psychiatry | 12 (71.0) | 5 (29.0) | 0.66 [0.21–2.02] | |
| Others | 22 (76.0) | 7 (24.0) | 0.78 [0.30–1.99] | |
| Total | 385 (71.0) | 158 (29.0) | ||
| Clinical pharmacists provide information on alternative drug regimens | Internal medicine | 100 (80.0) | 25 (20.0) | 1.00 |
| Pediatrics | 41 (73.0) | 15 (29.0) | 0.641 [0.29–1.38] | |
| Surgery | 21 (87.5) | 3 (12.5) | 1.18 [0.31–4.48] | |
| Emergency | 5 (71.0) | 2 (29.0) | 0.50 [0.08–2.90] | |
| Outpatient department | 31 (77.5) | 9 (22.5) | 0.63 [0.24–1.62] | |
| Gynecology/Obstetrics | 18 (64.0) | 10 (36.0) | 0.32 [0.12–0.83]* | |
| Psychiatry | 4 (67.0) | 2 (33.0) | 0.33 [0.05–2.10] | |
| Others | 10 (91.0) | 1 (9.0) | 1.60 [0.19–14.62] | |
| Total | 230 (77.0) | 67 (23.0) | ||
| Clinical pharmacists advise about cost effective medication alternatives | Internal medicine | 99 (80.0) | 25 (20.0) | 1.00 |
| Pediatrics | 39 (70.0) | 17 (30.0) | 0.53 [0.25–1.14] | |
| Surgery | 17 (71.0) | 7 (29.0) | 0.36 [0.12–1.07] | |
| Emergency | 5 (71.0) | 2 (29.0) | 0.53 [0.09–3.08] | |
| Outpatient department | 30 (75.0) | 10 (25.0) | 0.46 [0.18–1.14] | |
| Gynecology/Obstetrics | 18 (64.0) | 10 (36.0) | 0.32 [0.12–0.82]* | |
| Psychiatry | 4 (67.0) | 2 (33.0) | 0.31 [0.48–2.05] | |
| Others | 8 (73.0) | 3 (27.0) | 0.35 [0.07–1.60] | |
| Total | 220 (74.0) | 76 (26.0) | ||
| Clinical pharmacists participate in dose adjustment for pediatrics and patients with impaired renal and/or liver function*** | Internal medicine | 95 (77.0 | 29 (23.0) | 1.00 |
| Pediatrics | 38 (68.0) | 18 (32.0) | 0.62 [0.30–1.30] | |
| Surgery | 15 (62.5) | 9 (37.5) | 0.27 [0.09–0.79]* | |
| Emergency | 5 (71.0) | 2 (29.0) | 0.70 [0.12–4.08] | |
| Outpatient department | 28 (70.0) | 12 (30.0) | 0.43 [0.18–1.04] | |
| Gynecology/Obstetrics | 15 (54.0) | 13 (46.0) | 0.23 [0.09–0.60]* | |
| Psychiatry | 3 (50.0) | 3 (50.0) | 0.16 [0.02–1.05] | |
| Others | 9 (82.0) | 2 (18.0) | 0.68 [0.12–3.73] | |
| Total | 208 (70.0) | 88 (30.0) | ||
| Clinical pharmacists actively participate in bedside discussions to assist clinicians on therapeutic care plans and drug selection*** | Internal medicine | 88 (71.5) | 35 (28.5) | 1.00 |
| Pediatrics | 28 (50.0) | 28 (50.0) | 0.39 [0.20–0.78]* | |
| Surgery | 16 (67.0) | 8 (33.0) | 0.58 [0.21–1.58] | |
| Emergency | 3 (43.0) | 4 (57.0) | 0.28 [0.05–1.40] | |
| Outpatient department | 25 (62.5) | 15 (37.5) | 0.47 [0.21–1.06] | |
| Gynecology/Obstetrics | 16 (42.0) | 12 (58.0) | 0.41 [0.16–0.99]* | |
| Psychiatry | 3 (50.0) | 3 (50.0) | 0.26 [0.04–1.55] | |
| Others | 7 (64.0) | 4 (36.0) | 0.38 [0.09–1.49] | |
| Total | 186 (63.0) | 109 (37.0) | ||
| Clinical pharmacists participate in preventing, detecting and resolving any drug interactions | Internal medicine | 173 (75.0) | 57 (25.0) | 1.00 |
| Pediatrics | 77 (70.0) | 33 (30.0) | 0.74 [0.44–1.25] | |
| Surgery | 26 (68.0) | 12 (32.0) | 0.56 [0.26–1.23] | |
| Emergency | 20 (77.0) | 6 (23.0) | 0.97 [0.36–2.57] | |
| Outpatient Department | 45 (71.0) | 18 (29.0) | 0.71 [0.36–1.36] | |
| Gynecology/Obstetrics | 21 (58.0) | 15 (42.0) | 0.40 [0.19–0.87]* | |
| Psychiatry | 13 (76.0) | 4 (24.0) | 0.89 [0.27–2.90] | |
| Others | 20 (69.0) | 9 (31.0) | 0.53 [0.22–1.29] | |
| Total | 395(72.0) | 154(28.0) | ||
| Clinical pharmacists advise nurses on storage/handling of drugs | Internal medicine | 69 (62.0) | 43 (38.0) | 1.00 |
| Pediatrics | 36 (64.0) | 20 (36.0) | 1.02 [0.51–2.03] | |
| Surgery | 8 (57.0) | 6 (43.0) | 0.76 [0.24–2.39] | |
| Emergency | 12 (68.0) | 6 (33.0) | 1.24 [0.43–3.60] | |
| Outpatient department | 20 (83.0) | 4 (17.0) | 4.11 [1.14–14.76]* | |
| Gynecology/Obstetrics | 10 (83.0) | 2 (17.0) | 2.07 [0.40–10.69] | |
| Psychiatry | 5 (45.5) | 6 (54.5) | 0.55 [0.15–1.93] | |
| Others | 12 (66.7) | 6 (33.3) | 1.15 [0.39–3.38] | |
| Total | 172 (65.0) | 93 (35.0) |
Data was analyzed by multivariable logistic regression; * p < 0.05; *** Indicates the presence of non–response by respondents; The following other 16 items were found to be not significant. Clinical pharmacists are involved in drug preparation (reconstitution, reformulation, dilution); Clinical pharmacists assist nurses in managing drug infusion rates; Clinical pharmacists advise nurses on the compatibility of IV drug administration/admixture ; Clinical pharmacists document their services in patient care; Clinical pharmacists counsel patients regarding the safe and appropriate use of medications; Clinical pharmacists are involved in side effect prevention and management
Fig. 1Major contributions of clinical pharmacists in the hospital health care activities, September 2014
Fig. 2Limitations on current clinical pharmacy service from the health care providers perspective, September 2014